Mucinex DM (guaifenesin 600mg and dextromethorphan HBr 30mg), extended-release bi-layer tablets, ...

FDA Drug Recall #D-0964-2015 — Class III — November 10, 2014

Recall Summary

Recall Number D-0964-2015
Classification Class III — Low risk
Date Initiated November 10, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Reckitt Benckiser LLC
Location Parsippany, NJ
Product Type Drugs
Quantity 155 cases (2000 pouches of 2 tablets per case)

Product Description

Mucinex DM (guaifenesin 600mg and dextromethorphan HBr 30mg), extended-release bi-layer tablets, 2 tablets per pouch (NDC 63824-056-72), OTC, Distributed by Reckitt Benckiser, Parsippany, NJ 07054-0224 Made in England

Reason for Recall

Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch

Distribution Pattern

Nationwide

Lot / Code Information

Lot BD375 exp 06/2016; BD566, BD661 exp. 08/2016

Other Recalls from Reckitt Benckiser LLC

Recall # Classification Product Date
D-1517-2016 Class III Mucinex Sinus-Max Day Night, 60 caplets, Dist. ... Aug 3, 2016
D-1363-2015 Class I Mucinex Fast Max Cold, Flu & Sore Throat, Maxim... Apr 15, 2015
D-1364-2015 Class I Mucinex Fast Max Night Time Cold & Flu, Maximum... Apr 15, 2015
D-1365-2015 Class I Mucinex Fast-Max Cold & Sinus, Maximum Strength... Apr 15, 2015
D-1367-2015 Class I Mucinex Fast Max Severe Congestion & Cough, Max... Apr 15, 2015

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.